The role of advanced glycation end products in retinal microvascular leukostasis.
暂无分享,去创建一个
Yuichi Kaji | Alan W. Stitt | V. Poulaki | D. Archer | T. Gardiner | A. Adamis | I. Campbell | Tomohiko Usui | Tom A Gardiner | Alan W Stitt | Iain L Campbell | Anthony P Adamis | Y. Kaji | Vasiliki Poulaki | T. Usui | T. Moore | Tara C B Moore | Jonathan E Moore | Norma Frizzell | Desmond B Archer | N. Frizzell
[1] K Miyamoto,et al. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. , 2000, Investigative ophthalmology & visual science.
[2] V. Monnier,et al. Collagen Aging In Vitro by Nonenzymatic Glycosylation and Browning , 1984, Diabetes.
[3] T. Kislinger,et al. N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression* , 1999, The Journal of Biological Chemistry.
[4] A. Schmidt,et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. , 1995, The Journal of clinical investigation.
[5] L. Aiello,et al. Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. , 1998, Ophthalmic research.
[6] V. Monnier,et al. Mechanism of Protein Modification by Glyoxal and Glycolaldehyde, Reactive Intermediates of the Maillard Reaction (*) , 1995, The Journal of Biological Chemistry.
[7] R. Perry,et al. The gene family encoding the mouse ribosomal protein L32 contains a uniquely expressed intron-containing gene and an unmutated processed gene , 1984, Cell.
[8] A. Schmidt,et al. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. , 2001, American journal of physiology. Endocrinology and metabolism.
[9] K. Miyarnoto. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition , 1999 .
[10] Alan W. Stitt,et al. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. , 1997, The American journal of pathology.
[11] S. Krungkrai,et al. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[12] L. Aiello,et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Cooper,et al. Mechanisms of diabetic vasculopathy: an overview. , 2001, American journal of hypertension.
[14] A. Adamis,et al. Sensitive blood-retinal barrier breakdown quantitation using Evans blue. , 2001, Investigative ophthalmology & visual science.
[15] M. Matsumoto,et al. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[16] J. Baynes,et al. Role of the Maillard Reaction in Diabetes Mellitus and Diseases of Aging , 1996, Drugs & aging.
[17] E. Diamandis,et al. Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremia. , 1997, Kidney international.
[18] M. Lagarde,et al. In vitro and in vivo alterations of enzymatic glycosylation in diabetes. , 1999, Life sciences.
[19] T. Forst,et al. The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion molecules. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[20] B Kirchhof,et al. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. , 2001, The American journal of pathology.
[21] E. Kohner,et al. Activity of the glycosylating enzyme, core 2 GlcNAc (beta1,6) transferase, is higher in polymorphonuclear leukocytes from diabetic patients compared with age-matched control subjects: relevance to capillary occlusion in diabetic retinopathy. , 2000, Diabetes.
[22] J. Baynes,et al. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. , 1997, The Biochemical journal.
[23] A. Schmidt,et al. Atherosclerosis and diabetes: The rage connection , 2000, Current atherosclerosis reports.
[24] D. Archer,et al. The effect of endothelin 1 on the retinal microvascular pericyte. , 1992, Microvascular research.
[25] E. Friedman,et al. Hemoglobin-AGE: a circulating marker of advanced glycosylation. , 1992, Science.
[26] S. Schiekofer,et al. The role of oxidative stress and NF‐κB activation in late diabetic complications , 1999, BioFactors.
[27] H. Hammes,et al. Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model , 1995, Diabetologia.
[28] E. Diamandis,et al. The serum concentration of the advanced glycation end-product Nε-(carboxymethyl)lysine is increased in uremia: Technical Note , 1997 .
[29] P. Baeuerle,et al. Induction of Oxidative Stress by Okadaic Acid Is Required for Activation of Transcription Factor NF-κB (*) , 1995, The Journal of Biological Chemistry.
[30] E. Kohner,et al. Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy , 1997, Diabetologia.
[31] J. Baynes,et al. Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. , 1986, The Journal of biological chemistry.
[32] Alan W. Stitt,et al. Atherogenesis and Advanced Glycation: Promotion, Progression, and Prevention a , 1997, Annals of the New York Academy of Sciences.
[33] K. Matsumoto,et al. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. , 2000, Diabetes.
[34] J. Baynes,et al. Glycoxidation and lipoxidation in atherogenesis. , 2000, Free radical biology & medicine.
[35] K Miyamoto,et al. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). , 2000, The American journal of pathology.
[36] G. Romeo,et al. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. , 2000, Investigative ophthalmology & visual science.
[37] R. Roeder,et al. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.
[38] Alan W. Stitt,et al. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. , 1998, Diabetes.
[39] G. Yancopoulos,et al. VEGF-initiated blood-retinal barrier breakdown in early diabetes. , 2001, Investigative ophthalmology & visual science.
[40] F. Numano,et al. The Effect of Glucose and Advanced Glycosylation End Products on IL‐6 Production by Human Monocytes , 1994, Annals of the New York Academy of Sciences.
[41] B. Veldhuisen,et al. Nephrology Dialysis Transplantation Analysis of a large family with the second type of autosomal dominant polycystic kidney disease , 2005 .
[42] H. Hammes,et al. Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats , 1995, Diabetologia.
[43] H. Pertoft,et al. Separation of human monocytes on density gradients of Percoll. , 1980, Journal of immunological methods.
[44] E. Agardh,et al. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats. , 2000, Current eye research.
[45] H. Hammes,et al. Differential accumulation of advanced glycation end products in the course of diabetic retinopathy , 1999, Diabetologia.
[46] G. Striker,et al. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[47] T. Kern,et al. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. , 2001, Diabetes.
[48] Alan W. Stitt,et al. Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats. , 2000, Molecular cell biology research communications : MCBRC.